In spite of significant scientific progress in recent years, the aetiopathogenesis of chronic inflammatory bowel diseases (IBD) remains elusive. With a prevalence of 1:700 to 1:500 in central Europe, both diseases are not rare. However, most physicians will generally treat only a few patients with IBD in their clinical practice. Because of this limited experience and the variety of clinical IBD manifestations, IBD patients are frequently treated in specialized tertiary care centres. Nevertheless, IBD patients will also consult less specialized general practitioners, who will not be able to...

This book, the proceedings of a Falk Workshop on Topical Steroids in Gastroenterology and Hepatology', held in Berlin, Germany, on 14 June 2003, critically discusses the current role of budesonide in gastroenterology, hepatology, surgery and oncology and focuses especially on potential new indications for the use of budesonide. A number of smaller clinical studies and anecdotal case reports with impressive clinical effects are reported in patients with gastrointestinal, hepatic, oncological and surgical problems. In addition, the use of budesonide for the treatment of distal ulcerative...

Fortschritte bei der Erforschung, Diagnostik und Therapie chronisch entzA1/4ndlicher Darmkrankheiten (CED) bedA1/4rfen in zunehmendem MaAe einer interdisziplinAren Kooperation von klinischen Gastroenterologen, Radiologen, Immunologen, Dermatologen und Rheumatologen. Der vorliegende Band fasst den aktuellen Stand zu extraintestinalen Komplikationen chronisch entzA1/4ndlicher Darmkrankheiten zusammen. Eingehend und kritisch diskutiert werden Manifestationen an der Haut, die wichtige Komplikation der Osteopenie, Gelenkmanifestationen und LeberverAnderungen. Es werden Spezialaspekte von CED in...